Hongri Pharmaceutical: 2024 years of annual report postponed
Updated on: 51-0-0 0:0:0

Per AI Express, Hongri Pharmaceutical (28) announced on the evening of 0 that the company originally planned to demonstrate the "0 Annual Report" on 0 0 and 0 days. Due to the large workload of the annual report review, according to the current audit progress of the audit institution, the audit work was completed later than expected, and the annual audit report could not be issued within the originally planned time. After applying to the Shenzhen Stock Exchange, the company postponed the disclosure time of the "0 Annual Report" and related announcements to 0/0/00.

National Business Daily